{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:59:27Z","timestamp":1786460367061,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013221","name":"Razi Vaccine and Serum Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.heliyon.2024.e40124","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:26:19Z","timestamp":1730863579000},"page":"e40124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-3582","authenticated-orcid":false,"given":"Esmat","family":"Malek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Fallah Mehrabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Es-haghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Nofeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Rezae","family":"Mokaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monireh Haji","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyad Hossein","family":"Razaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Solaymani-Dodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Mokhberalsafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Banihashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e40124_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.micinf.2020.02.002","article-title":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future","volume":"22","author":"Li","year":"2020","journal-title":"Microb. Infect."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e40124_bib2","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update","volume":"12","author":"Pal","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e40124_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e40124_bib4","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1056\/NEJMoa2115926","article-title":"Protection against Covid-19 by BNT162b2 booster across age groups","volume":"385","author":"Bar-On","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e40124_bib5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/vaccines10111781","article-title":"Short-term adverse effects following booster dose of inactivated-virus vs. adenoviral-vector COVID-19 vaccines in Algeria: a cross-sectional study of the general population","volume":"10","author":"Lounis","year":"2022","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e40124_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14760584.2022.2035222","article-title":"COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies","volume":"21","author":"Di Fusco","year":"2022","journal-title":"Expet Rev. Vaccine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40124_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/dom.14643","article-title":"Humoral immune response to COVID\u201019 vaccination in diabetes is age\u2010dependent but independent of type of diabetes and glycaemic control: the prospective COVAC\u2010DM cohort study","volume":"24","author":"Sourij","year":"2022","journal-title":"Diabetes Obes. Metabol."},{"issue":"10328","key":"10.1016\/j.heliyon.2024.e40124_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"The lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40124_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12879-022-07418-y","article-title":"SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis","volume":"22","author":"Ssentongo","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e40124_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e40124_bib11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nature medicine"},{"key":"10.1016\/j.heliyon.2024.e40124_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.imj.2023.08.005","article-title":"A review of SARS-CoV-2 variants and vaccines: viral properties, mutations, vaccine efficacy, and safety","author":"Islam","year":"2023","journal-title":"Infectious Medicine"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e40124_bib13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e40124_bib14","article-title":"A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine","volume":"13","author":"Malayala","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e40124_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ejh.13855","article-title":"COVID\u201019: vaccine\u2010induced immune thrombotic thrombocytopenia","volume":"109","author":"Danish","year":"2022","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40124_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ene.15113","article-title":"Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS\u2010CoV\u20102 vaccination","volume":"29","author":"van de Munckhof","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e40124_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e40124_bib18","article-title":"Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination","volume":"3","author":"Sanchez Tijmes","year":"2021","journal-title":"Radiology: Cardiothoracic Imaging"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40124_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/vaccines10050722","article-title":"Risk of myocarditis and pericarditis among young adults following mRNA COVID-19 vaccinations","volume":"10","author":"Alami","year":"2022","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e40124_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcr\/ytab371","article-title":"Myopericarditis in a teenager following first mRNA COVID vaccine dose: the role of multi-parametric cardiovascular magnetic resonance","volume":"5","author":"Chen","year":"2021","journal-title":"European Heart Journal-Case Reports"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40124_bib21","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","volume":"41","author":"Jara","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e40124_bib22","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.xphs.2023.09.027","article-title":"Phase II, safety and immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 vaccine in adults aged 18\u201370 years; a randomized, double-blind clinical trial","volume":"112","author":"Mohazzab","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40124_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-024-03295-1","article-title":"Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial","volume":"22","author":"Erfanpoor","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.heliyon.2024.e40124_bib24","article-title":"Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine: an interim analysis","author":"Toback","year":"2023","journal-title":"medRxiv"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e40124_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011744","article-title":"Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals","volume":"19","author":"Eybpoosh","year":"2023","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e40124_bib26","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1038\/s41598-023-35147-y","article-title":"PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals","volume":"13","author":"Ramezani","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e40124_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hrtlng.2023.02.003","article-title":"Cardiovascular complications of COVID-19 vaccines: a review of case-report and case-series studies","volume":"59","author":"Paknahad","year":"2023","journal-title":"Heart Lung"},{"key":"10.1016\/j.heliyon.2024.e40124_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103340","article-title":"Insights into new-onset autoimmune diseases after COVID-19 vaccination","author":"Guo","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e40124_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/bioengineering10020148","article-title":"Advanced vaccine design strategies against SARS-CoV-2 and emerging variants","volume":"10","author":"Zhang","year":"2023","journal-title":"Bioengineering"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e40124_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/vaccines10040608","article-title":"COVID-19 vaccines: current and future perspectives","volume":"10","author":"Soraci","year":"2022","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e40124_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27370","article-title":"Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: a phase III, non-inferiority trial","volume":"10","author":"Solaymani-Dodaran","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e40124_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.836745","article-title":"Safety and efficacy of combined intramuscular\/intranasal RAZI-COV PARS vaccine candidate against SARS-CoV-2: a preclinical study in several animal models","volume":"13","author":"Banihashemi","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e40124_bib33","article-title":"Efficacy and safety of COVID-19 vaccines: a systematic review","volume":"23","author":"Kai","year":"2021","journal-title":"Chin. J. Contemp. Pediatr"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024161555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024161555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:46:47Z","timestamp":1786452407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024161555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2405844024161555"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40124","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e40124"}}